Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2013
10/24/2013US20130280783 Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
10/24/2013US20130280350 Herbal topical formulation
10/24/2013US20130280336 Nanoparticle comprising rapamycin and albumin as anticancer agent
10/24/2013US20130280334 Nanostructured Gels Capable of Controlled Release of Encapsulated Agents
10/24/2013US20130280331 Depot Compositions with multiple drug release rate controls and uses thereof
10/24/2013US20130280330 Microsphere drug carrier, preparation method, composition and use thereof
10/24/2013US20130280327 Zolpidem-based orodispersible pharmaceutical tablet
10/24/2013US20130280326 Pharmaceutical composition for oral administration intended to prevent misuse
10/24/2013US20130280324 Sustained release pharmaceutical compositions comprising pregabalin
10/24/2013US20130280316 Biodegradable non-ophthalmic implants and related methods
10/24/2013US20130280306 Block copolymers for stable micelles
10/24/2013US20130280305 Cationic lipid
10/24/2013US20130280304 Method of administration of active agents to non-human mammals
10/24/2013US20130280282 Dr5 ligand drug conjugates
10/24/2013US20130280279 Pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide
10/24/2013US20130280250 Dock-and-Lock (DNL) Constructs for Human Immunodeficiency Virus (HIV) Therapy
10/24/2013US20130280248 Method of stabilizing antibody and stabilized solution-type antibody preparation
10/24/2013US20130280237 Protein transduction domains mimics
10/24/2013US20130280206 Stabilized polymeric thiol reagents
10/24/2013US20130280204 Polymer-Attached Inhibitors of Influenza Virus
10/24/2013US20130280168 Flexible and/or Elastic Brachytherapy Seed or Sirand
10/24/2013US20130280163 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
10/24/2013US20130280162 uPAR-ANTAGONISTS AND USES THEREOF
10/24/2013CA2842041A1 Poly(acrylate) polymers for in vivo nucleic acid delivery
10/23/2013EP2653545A1 Methods and compositions
10/23/2013EP2653544A1 Methods and compositions
10/23/2013EP2653543A1 Methods and Compositions
10/23/2013EP2653153A1 Anti-malarial pharmaceutical composition
10/23/2013EP2653041A1 Oxidation reaction product of hop extract, process for production thereof, and use thereof
10/23/2013EP2652137A1 Lar protein-specific ligand
10/23/2013EP2651864A1 Methods and devices for using isoperillyl alcohol
10/23/2013EP2651453A1 Compounds for diagnosing diseases associated with the expression of muc5ac
10/23/2013EP2651450A2 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
10/23/2013EP2651449A2 Chimeric fibronectin matrix mimetics and uses thereof
10/23/2013EP2651448A2 Functionalized polymers
10/23/2013EP2651447A1 Entrapment of radionuclides in nanoparticle compositions
10/23/2013EP2651446A1 Preparation comprising insulin, nicotinamide and an amino acid
10/23/2013EP2651445A2 Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications
10/23/2013EP2651433A1 Aqueous factor viii solution
10/23/2013EP2651432A1 Fast-acting insulin in combination with long-acting insulin
10/23/2013EP2651409A1 Novel pharmaceutical formulation comprising nsaid and cyclodextrin
10/23/2013EP2651407A2 3-methanesulfonylpropionitrile for treating inflammation and pain
10/23/2013EP2651402A1 Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
10/23/2013EP2651396A2 Pharmaceutical compositions
10/23/2013EP2651394A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
10/23/2013EP2651393A1 Sterile injectable aqueous formulation used in ophthalmology
10/23/2013EP2651243A1 New particle stabilized emulsions and foams
10/23/2013CN203244609U Persistent type hydrogel patch
10/23/2013CN103370084A Use of aniline in the radiostabilization of oxime ligation
10/23/2013CN103370083A Engineered polypeptides having enhanced duration of action
10/23/2013CN103370082A Nucleophilic catalysts for oxime linkage
10/23/2013CN103370069A Method and formulations for treating sialic acid deficiencies
10/23/2013CN103370064A Drug formulations using water soluble antioxidants
10/23/2013CN103370055A Long-lasting controlled-release liposome composition and method for producing same
10/23/2013CN103370052A Nanoparticles comprising at least one active agent and at least two polyelectrolytes
10/23/2013CN103360609A Novel amphiphilic protein-high molecule bonding body and preparation method thereof
10/23/2013CN103360608A Method for preparing comb-like polylactic acid by direct polycondensation
10/23/2013CN103360607A Preparation method of magnetic responsiveness star type segmented copolymer nanometer micelle
10/23/2013CN103360590A Preparation method of methoxy polyethylene glycol-bi-fatty acryl phosphatidyl ethanolamine
10/23/2013CN103360512A Production method for pharmaceutic adjuvant pectin
10/23/2013CN103357024A Liver cancer suicide gene therapy medicine based on aminated silicon dioxide nanoparticle-CD/TK (cytosine deaminase-thymidine kinase) fused gene compound
10/23/2013CN103357023A Method for increasing solubility of 10-hydroxycamptothecin, product prepared by the method and applications of the product
10/23/2013CN103357022A Bifunctional polyethylene glycol and adriamycin conjugate and preparation method thereof
10/23/2013CN103357021A Pharmaceutical composition using albumin as pharmaceutical carrier
10/23/2013CN103357020A Method for preparing protein-based chitosan nanoparticles and application of chitosan nanoparticles serving as nucleic acid drug carriers
10/23/2013CN103357019A Application of gastrodin used as co-solvent and preparation method of injection solution or powder injection for injecting
10/23/2013CN103357016A Pharmaceutical composition for treating drug-resistant tuberculosis
10/23/2013CN103357012A Taxane self-emulsifying or self-microemulsifying drug transfer system and preparation method thereof
10/23/2013CN103357005A Live attenuated rotavirus vaccine for oral administration
10/23/2013CN103356998A Composition for treating human white hair and/or leucoderma and application thereof
10/23/2013CN103356997A Pharmaceutical compositions comprising HGH for oral delivery
10/23/2013CN103356995A Hgf制剂 Hgf preparations
10/23/2013CN103356986A Spleen-warming and diarrhea-stopping pills, and preparation method thereof
10/23/2013CN103356967A Chinese herbal compound extract with effect of resisting proliferation of mammary gland, and preparation method thereof
10/23/2013CN103356891A Sugar-free throat-clearing lozenge and preparation method thereof
10/23/2013CN103356763A Method for preparing orifice-opening rhinitis spray
10/23/2013CN103356750A Compound nanoemulsion preparation for treatment of cold and preparation method thereof
10/23/2013CN103356739A Shuanghuanglian oral liquid for livestock and extraction method thereof
10/23/2013CN103356723A Cooling paste for children and preparation method thereof
10/23/2013CN103356722A Angelica dahurica total coumarin solid dispersion and preparation method therefor
10/23/2013CN103356693A Compound low-molecular heparin sodium liposome gel and preparation method and application thereof
10/23/2013CN103356662A Injection tigecycline composition and preparation method thereof
10/23/2013CN103356631A Doxofylline composition for injection
10/23/2013CN103356619A Medicinal composition
10/23/2013CN103356618A Tropisetron composition for injection
10/23/2013CN103356616A Bilastine-containing pharmaceutical composition and preparation method thereof
10/23/2013CN103356511A Protein drug transdermal drug delivery patch
10/23/2013CN103356510A Methods for producing drug-containing bioabsorbable fibers
10/23/2013CN103356508A Centella total glycoside cataplasm and preparation method thereof
10/23/2013CN103356504A 4-Amino-2-trifluoromethylphenylretinoate self-microemulsion and preparation method thereof
10/23/2013CN103356501A Risperidone tablet and preparation method thereof
10/23/2013CN103356499A Dextran-MLDH-fluorouracil supermolecular assembly magnetic targeting sustained release tablet
10/23/2013CN103356498A Mosapride citrate dehydrate sustained release tablet
10/23/2013CN103356497A Benzenesulfonate amlodipine tablet and preparation method thereof
10/23/2013CN103356495A Letrozole tablet and preparation method thereof
10/23/2013CN103356494A High-stability simvastatin tablets and preparation method thereof
10/23/2013CN103356493A Preparation method of amlodipine besylate tablets
10/23/2013CN103356492A Tripterine pharmaceutical composition using albumin as pharmaceutical carrier
10/23/2013CN103356491A Preparation method of syringopicroside (SYR) poly(lactide-co-glycolide) (PLGA) nanoparticles
10/23/2013CN103356490A Cross-linked food protein stabilized nanometer medicament delivery system capable of being solidified directly
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 1712